1. Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis?
- Author
-
Houtkamp MA, van Der Wal AC, de Boer OJ, van Der Loos CM, de Boer PA, Moorman AF, and Becker AE
- Subjects
- Aged, Arteries immunology, Arteries pathology, Arteriosclerosis genetics, Arteriosclerosis pathology, Cell Line, Female, Humans, Immunohistochemistry, Interleukin-15 genetics, Interleukin-15 pharmacology, Male, Middle Aged, RNA, Messenger biosynthesis, T-Lymphocytes drug effects, Transcription, Genetic, Arteriosclerosis immunology, Interleukin-15 biosynthesis, Lymphocyte Activation, T-Lymphocytes immunology
- Abstract
T-cell activation in atherosclerotic plaques is thought to be initiated by plaque-derived antigens, such as oxidized LDL (oxLDL). An alternative pathway of T-cell activation independent of antigen stimulation, mediated by the cytokine interleukin (IL)-15, was recently described. We investigated IL-15 expression in atherosclerotic plaques in relation to plaque morphology, inflammatory cells, T-cell activation, and oxidation-specific epitopes by use of immunohistochemistry. In situ hybridization was used to evaluate IL-15 mRNA expression. We also studied the proliferative response of plaque-derived T-cell lines to IL-15 in vitro using [(3)H]thymidine incorporation. Fresh-frozen specimens were classified as fibrous (n=9), fibrolipid (n=8), and lipid-rich (n=14) plaques; normal vessels (n=4) served as reference. Expression of IL-15 mRNA and protein was found almost solely in fibrolipid and lipid-rich plaques, associated with oxLDL-positive macrophages. Sequential immunostains revealed colocalization between IL-15- and CD40L-positive T cells. Moreover, plaque-derived T-cell lines were highly responsive to IL-15. Hence, IL-15 could provide a pathway for antigen-independent T-cell activation.
- Published
- 2001
- Full Text
- View/download PDF